Addus HomeCare (NASDAQ:ADUS) EVP David Tucker Sells 379 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP David Tucker sold 379 shares of the company’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total transaction of $39,931.44. Following the transaction, the executive vice president directly owned 10,423 shares of the company’s stock, valued at $1,098,167.28. This represents a 3.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Addus HomeCare Stock Performance

ADUS stock traded down $3.58 during trading on Thursday, reaching $104.02. 269,378 shares of the stock were exchanged, compared to its average volume of 239,147. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $1.92 billion, a P/E ratio of 19.97, a price-to-earnings-growth ratio of 1.26 and a beta of 0.91. The stock has a 50 day simple moving average of $109.57 and a 200-day simple moving average of $113.08.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Wednesday. BMO Capital Markets initiated coverage on shares of Addus HomeCare in a research report on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price on the stock. Finally, KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $134.33.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently made changes to their positions in the company. Royal Bank of Canada boosted its position in Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after buying an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after acquiring an additional 2,952 shares during the last quarter. Jane Street Group LLC raised its stake in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after acquiring an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC boosted its holdings in shares of Addus HomeCare by 44.7% in the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after acquiring an additional 4,439 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Key Headlines Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.